Therefore, at least for BRCA1, the MLPA test should be considered for breast cancer patients with a family history of breast and/or ovarian cancer and additional personal factors such as bilateral breast cancer, young age at onset, and TNBC during the genetic counseling process. This evidence concerns the gene BRCA1 and ovarian cancer.